Background: The value of serum thyroglobulin/antithyroglobulin (Tg/antithyroglobulin
antibody [ATg]) for papillary thyroid carcinoma (PTC) surveillance after lobectomy was …

Background The role of measuring serum thyroglobulin (Tg) levels in patients who have
undergone lobectomy has not been proven. The goal of this research is to see if serum Tg …

Background: Low-risk patients with differentiated thyroid cancer can be treated with thyroid
lobectomy. Serial measurements of serum thyroglobulin (Tg) are recommended for …

Background: Thyroidectomy followed by administration of large activities of 131I is the
treatment of choice for differentiated thyroid carcinomas. Due to its good prognosis, some …

Background The use of thyroglobulin (Tg) and thyroglobulin antibodies (TgAb) for detecting
disease recurrence is well validated following total thyroidectomy and radioiodine ablation …

Background: Thyroglobulin is an excellent biological marker of persistent or recurrent thyroid
cancer during long-term follow-up. Most studies investigated its diagnostic value but not its …

Objective To determine the relationship between stimulated serum thyroglobulin levels
(taken 3 months after total thyroidectomy) and tumor stage and recurrence in patients with …

Background: In papillary thyroid carcinoma (PTC), recurrences during long-term follow-up (R-
LTFU) occur even in those who appear to have an excellent prognosis after initial thyroid …

Objective To study whether post-surgical and/or post-ablative thyroglobulin (Tg)
concentrations may serve as independent predictors of disease recurrence in patients …

Objectives The prognostic role of thyroglobulin in predicting recurrence in differentiated
thyroid cancer (DTC) patients treated by lobectomy is controversial. This systematic review …